May 20, 2024
A Georgia federal judge has signed off on a nearly $41.5 million class action settlement with Acella Pharmaceuticals LLC over faulty thyroid medication, while awarding the class attorneys another $5 million in legal fees courtesy of the pharma company.
May 01, 2024
Plaintiffs' attorneys who recently reached a $46.5 million class action settlement with Acella Pharmaceuticals LLC over faulty thyroid medication asked a Georgia federal judge Tuesday to sign off on their $5 million cut of the deal as a "presumptively reasonable" proposal.
February 07, 2024
A Georgia federal judge on Wednesday gave preliminary approval of a nearly $46.5 million settlement from Acella Pharmaceuticals LLC to end a class action alleging the company sold worthless thyroid medication to hundreds of thousands of Americans.
February 05, 2024
A proposed agreement to end a class action over thyroid medication, after a U.S. Food and Drug Administration inspection found products with an active ingredient above and below label specifications, may cost Acella Pharmaceuticals $46.5 million.
July 11, 2023
Acella Pharmaceuticals can't escape a proposed class action over its recalled thyroid medication, a Georgia federal judge ruled, calling some of the company's assertions as to why the plaintiffs could never secure class certification "a bit disingenuous."
May 13, 2022
Acella Pharmaceuticals is facing down a proposed class action in Georgia federal court over its recalled thyroid medication, which plaintiffs claim was released untested and caused them harm.